United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for TruBridge, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
| ROE | -11.59% | -12.18% | -10.95% | -23.11% | -42.51% | -73.22% |
|---|---|---|---|---|---|---|
| ROA | -4.95% | -4.72% | -3.5% | -5.79% | -7.18% | -6.77% |
| Gross Margin | 50.81% | 49.74% | 48.39% | 47.77% | 46.47% | 46.64% |
| Net Margin | -5.97% | -4.93% | -3.64% | -5.85% | -7.3% | -6.91% |
| Total Assets | $394,432.00K | $426,091.04K | $460,391.84K | $497,556.65K | $537,826.59K | $580,790.25K |
| Net Income | -$20,439.00K | -$19,369.91K | -$15,506.01K | -$27,727.09K | -$37,191.97K | -$37,837.74K |